Bolt Biotherapeutics, Inc. (BOLT) Two-Stage Excess Return Model - Discounting Cash Flows
Bolt Biotherapeutics, Inc.
BOLT (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Two-Stage Excess Return Model

Used to estimate the value of companies based on two stages of growth. An initial period of high growth, represented by [Sum of discounted excess returns in Growth Stage], followed by a period of stable growth, represented by [Discounted excess return in terminal stage]. Excess Return models are better suited to calculate the intrinsic value of a financial company than an enterprise valuation model (such as the Discounted Free Cash Flow Model).

Read more: GitHub Documentation

Interactive Assumptions

Results

Estimated Value 14.53 USD
Book value of equity invested 1.22 USD
Sum of discounted excess returns in Growth Stage 1.89 USD
Terminal stage EPS 0.931 USD
Terminal stage Book Value 3.2 USD
Terminal stage Equity Cost 0.262 USD
Discounted excess return in terminal stage 11.42 USD
Excess Returns in the Terminal Stage 16.93 USD
Terminal Cost of Equity (the discount rate) 8.19%
Terminal year's excess return 0.669 USD
Average historical Return on Equity 29.13%
Average historical Payout Ratio -21.56%
Payout Ratio in stable stage 85.44%
Yield of the U.S. 10 Year Treasury Bond 4.24%

Historical and Forecasted Data

In USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Beginning Book Value 2.98 1.5 1.5 1.93 2.38 2.78 3.07
Ending Book Value 1.5 1.22 1.93 2.38 2.78 3.07 3.2
EPS -1.65 -1.67 0.436 0.564 0.693 0.809 0.893
Return on Equity -55.98% -110.8% 29.13% 29.13% 29.13% 29.13% 29.13%
Dividend per Share
0.36 -0.001 0.12 0.296 0.518 0.763
Payout Ratio -0.157% -21.56% -0.157% 21.24% 42.64% 64.04% 85.44%
Retained Earnings
-2.03 0.437 0.444 0.397 0.291 0.13
Equity Cost 0.244 0.123 0.123 0.159 0.195 0.227 0.251
Cost of Equity 8.19% 8.19% 8.19% 8.19% 8.19% 8.19% 8.19%
Excess Return -1.89 -1.79 0.314 0.405 0.498 0.581 0.642
Discounted Excess Return
0.29 0.346 0.393 0.424 0.433

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Net Income -62.47 -63.35 -63.12 -69.2 -85.88 -104.4 -72.27 -30 -11.59
Total Stockholders Equity 58.95 46.81 57.2 112.7 171.5 250.1 -104.9 -45.85 -15.94
Return on Equity 29.12% -110.8% -55.98% -40.35% -34.33% 99.47% 157.6% 188.2% 29.13% 29.13% 29.13% 29.13%
Dividends Paid to Common Shareholders 13.8 13.8
Payout Ratio -2.1% -21.56% -0.157% -0.157% -0.157% -0.157% -0.157% -0.157% -0.157% -0.157% -0.157% -0.157%
Shares Outstanding 33.73 38.34 38.18 37.81 37.36 37.4 36.25 35.1 9.42
Earnings per Share -1.79 -1.67 -1.65 -1.83 -2.3 -2.79 -1.99 -0.85 -1.23
Dividend per Share 0.36 0.36
Dividend Growth Rate
Book Value 1.38 1.22 1.5 2.98 4.59 6.69 -2.9 -1.31 -1.69
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us